|
|
|
|
Document Preview Revolving Line of Credit Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Revolving Line of Credit Agreement |
|||
|
Entities: |
Abbott Laboratories; BioTime, Inc.; Alfred D. Kingsley |
|||
|
Date: |
2002 |
|||
|
Size: |
Preview shows 11KB of 112KB total |
|||
|
Price: |
$62 |
|||
|
ID: |
#284721 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
REVOLVING LINE OF CREDIT AGREEMENT
by and between
BIOTIME, INC.
as "Borrower"
and
ALFRED D. KINGSLEY
as "Lender"
Dated as of March 27, 2002
{PAGE}
TABLE OF CONTENTS
1. General Definitions...................................................1
2. Draws and Disbursements...............................................2
3. Terms of Payment......................................................4
4. Warrant...............................................................5
5. Events of Default.....................................................5
6. Remedies On Default...................................................6
7. Representations and Warranties of Borrower............................6
8. Affirmative Covenants.................................................8
9. Fees and Charges of Attorneys and Others..............................9
10. Maximum Permitted Interest...........................................10
11. Governing Law........................................................10
12. Successors and Assigns...............................................10
13. Entire Agreement; Amendment..........................................10
14. Survival.............................................................10
15. Notices..............................................................10
16. Delays and Omissions.................................................11
17. Rules of Construction................................................11
18. Severability.........................................................11
19. Counterparts.........................................................12
i
{PAGE}
REVOLVING LINE OF CREDIT AGREEMENT
This Revolving Line of Credit Agreement ("Credit Agreement") is made
and entered into as of March 27, 2002, by and between Alfred D. Kingsley
("Lender"), and BioTime, Inc., a California corporation ("Borrower").
RECITALS
Borrower has requested a credit facility consisting of a revolving line of
credit, and Lender is willing to make the requested credit facility to Borrower,
but only upon the terms, and subject to the conditions, contained herein.
AGREEMENT
Now, therefore, in consideration of the premises and the mutual covenants
hereinafter contained, the parties hereto agree as follows:
1. General Definitions. The following words shall have the following
meanings:
1.1 "Business Day" means any day that is not a Saturday, a
Sunday, or a day on which banks are required, or permitted, to be closed in the
State of New York.
1.2 "Credit Facility" means the right of Borrower to borrow up
to $300,000 from Lender under the terms and conditions of this Credit Agreement
and the Note.
1.3 "Debtor Relief Law" means the Bankruptcy Code of the
United States of America, as amended, or any other applicable liquidation,
conservatorship, bankruptcy, moratorium, rearrangement, receivership,
insolvency, reorganization, or similar debtor relief law affecting the rights of
creditors generally.
1.4 "Event of Default" or "Events of Default" means any of the
events specified in Section 5, 19.
1.5 "Loan" means the loans made by Lender to Borrower pursuant
to this Credit Agreement, and evidenced by the Note.
1.6 "Loan Documents" means this Credit Agreement, the Note,
the Warrant Agreement, and all other agreements, instruments, and documents in
favor of Lender, now or hereafter executed by or on behalf of Borrower and
delivered to Lender in connection with this Credit Agreement or in connection
with any of the transactions contemplated hereby.
1.7 "Maturity Date" means the earlier of (i) March 31, 2003,
and (ii) such date on which Borrower shall have received an aggregate of
$600,000 through (A) the sale of capital stock, (B) the collection of license
fees, signing fees, milestone fees, or similar fees under
1
{PAGE}
Borrower's Exclusive License Agreement with Abbott Laboratories or under any
other present or future agreement pursuant to which Borrower grants one or more
licenses to use Borrower's patents or technology, (C) funds borrowed from other
lenders, or (D) any combination of sources under clauses (A) through (C).
1.8 "Note" means the promissory note, of even date, in the
form attached as EXHIBIT A, evidencing the Loan to be executed concurrently with
this Credit Agreement.
1.9 "Warrant" means the stock purchase warrant issued under
the Warrant Agreement attached as EXHIBIT B, entitling the holder thereof to
purchase common shares of the Borrower.
2. Draws and Disbursements.
2.1 Maximum Loan Amount. On the terms and conditions set forth
in this Credit Agreement, Lender shall make available to Borrower the Credit
Facility, as a revolving line of credit in a principal amount not to exceed at
any one time Three Hundred Thousand Dollars ($300,000), less all amounts of
principal prepaid or required to be prepaid under Section 3.2.1 of this Credit
Agreement (the "Maximum Loan Amount").
2.2 Draw Period. Borrower may request from Lender advances of
funds ("Draws") under the Credit Facility from the date of this Agreement until
March 1, 2003 (the "Draw Period"). As amounts drawn by Borrower hereunder are
repaid, they may be reborrowed subject to the terms and conditions of this
Credit Agreement; provided, that at no time shall the aggregate principal amount
of Loans outstanding under this Credit Agreement exceed the Maximum Loan Amount.
The Draw Period may be terminated by Borrower at any time by written notice to
Lender. Subject to the terms and conditions of this Credit Agreement, and
provided that no Event of Default has occurred, Lender shall make advances to
Borrower upon request as provided in this Section 2. Upon the occurrence of an
Event of, one of Lender's remedies includes Lender's right to terminate the Draw
Period and Borrower's right to make Draws under this Credit Agreement.
2.3 Increments. Draws must be in increments of not less than
One Hundred Thousand Dollars ($100,000), or the remaining amount available under
the Credit Facility, whichever is less.
2.4 Use of Funds. All funds borrowed under this Credit
Agreement will be used as working capital to pay Borrower expenses arising in
the ordinary course of business.
2
{PAGE}
2.5 Disbursement Procedures.
2.5.1 Borrower hereby appoints its Chief Executive
Officer, President, and Chief Financial Officer as the officers authorized to
make Draws under this Credit Agreement during the Draw Period. Any one of such
officers (the "Authorized Officers") is authorized to make Draws. Lender, at its
sole option, may require that all requests for Loan funds be in writing, signed
by an Authorized Officer, in a form acceptable to Lender. Facsimile documents
may be accepted by Lender as originals. Any Draw by an Authorized Officer shall
constitute an ongoing representation and warranty by Borrower that at the time
of request for or payment of any Draw no Event of Default has occurred.
2.5.2 Draws shall be paid according to the Authorized
Officer's instructions, except that checks representing Loan funds shall always
be made payable to Borrower, and wire transfers shall only be permitted if
Borrower has authorized payment into the account into which the funds are to be
deposited. The appointment of the above-named Authorized Officer(s) shall remain
in full force and effect until written notice of revocation of appointment
signed by the Chief Executive Officer or Chief Financial Officer of Borrower has
been received by Lender.
2.5.3 Lender shall advance Loan funds available under
the Credit Facility in accordance with Borrower's Draws within four (4) Business
Days after the receipt of the Draw.
2.5.4 Each Draw shall be accompanied by the
certificates required by Section 2.6.
2.5.5 Borrower shall indemnify and hold Lender
harmless from loss or liability of any kind arising from or related to any
action or inaction taken by Lender in good faith in reliance upon instructions
received from any Authorized Officer.
2.6 Conditions Precedent. The following conditions must be satisfied
before Lender shall be obligated to disburse Loan funds to Borrower pursuant to
a Draw:
2.6.1 Due execution. Lender shall have received duly
originals of this Credit Agreement and all other Loan Documents.
2.6.2 Approvals. Lender shall have received evidence
|
End of Preview |
Home Intelligence Services Subscriptions News About Us